Formycon AG

Formycon AGverified

FYB.DE

Price:

$24.85

Market Cap:

$438.96M

Formycon AG develops and markets biosimilar products. Its product pipeline includes FYB201, a biosimilar candidate for Lucentis, an ophthalmic drug used in the treatment of neovascular age-related macular degeneration and other serious eye diseases; FYB202, a biosimilar candidate for Stelara, a biopharmaceutical used in the treatment of inflammatory diseases, such as moderate to severe psoriasis, as well as for the treatment of Crohn's disease and ulcerative colitis, which is in the Phase III clinical trial; and FYB203, a biosimilar candidate for Eylea to treat neovascular age-related macular degeneration and other eye diseases that is in Phase III clinical trials. The company is also develo...[Read more]

Industry

Biotechnology

IPO Date

2011-01-04

Stock Exchange

XETRA

Ticker

FYB.DE

The ROE as of December 2025 (TTM) for Formycon AG (FYB.DE) is -39.02%

According to Formycon AG’s latest financial reports and current stock price. The company's current ROE is -39.02%. This represents a change of 516.15% compared to the average of -6.33% of the last 4 quarters.

Formycon AG (FYB.DE) Historical ROE (quarterly & annually)

How has FYB.DE ROE performed in the past?

The mean historical ROE of Formycon AG over the last ten years is -4.24%. The current -39.02% ROE has changed 819.34% with respect to the historical average. Over the past ten years (40 quarters), FYB.DE's ROE was at its highest in in the June 2018 quarter at 22.90%. The ROE was at its lowest in in the June 2012 quarter at -47.50%.

Quarterly (TTM)
Annual

Average

-4.24%

Median

-5.47%

Minimum

-27.21%

Maximum

21.36%

Formycon AG (FYB.DE) ROE by Quarter and Year

Discovering the peaks and valleys of Formycon AG ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 140.42%

Maximum Annual ROE = 21.36%

Minimum Annual Increase = -938.19%

Minimum Annual ROE = -27.21%

Quarterly (TTM)
Annual
YearROEChange
2024-27.21%-280.49%
202315.08%49.36%
202210.09%-142.45%
2021-23.78%140.42%
2020-9.89%107.92%
2019-4.76%-122.27%
201821.36%-444.95%
2017-6.19%-68.19%
2016-19.46%-938.19%
20152.32%-64.61%

Formycon AG (FYB.DE) Average ROE

How has FYB.DE ROE performed in the past?

The current ROE of Formycon AG (FYB.DE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-0.68%

5-year avg

-7.14%

10-year avg

-4.24%

Formycon AG (FYB.DE) ROE vs. Peers

How is FYB.DE’s ROE compared to its peers?

Formycon AG’s ROE is greater than Verastem, Inc. (-9587.28%), greater than Zura Bio Limited (-51.70%), less than Medios AG (4.26%), less than Stratec SE (6.23%), greater than Heidelberg Pharma AG (-123.22%), less than Newron Pharmaceuticals S.p.A. (1.67%), greater than 4basebio PLC (-63.53%), greater than BRAIN Biotech AG (-133.24%), less than M1 Kliniken AG (15.83%), greater than High Tide Inc. (-6.91%),

CompanyROEMarket cap
-9587.28%$390.47M
-51.70%$237.98M
4.26%$359.12M
6.23%$268.65M
-123.22%$115.56M
1.67%$507.00M
-63.53%$100.65M
-133.24%$55.93M
15.83%$335.00M
-6.91%$201.66M

Build a custom stock screener for Formycon AG (FYB.DE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Formycon AG using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Formycon AG (FYB.DE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Formycon AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Formycon AG's ROE?

How is the ROE calculated for Formycon AG (FYB.DE)?

What is the highest ROE for Formycon AG (FYB.DE)?

What is the 3-year average ROE for Formycon AG (FYB.DE)?

What is the 5-year average ROE for Formycon AG (FYB.DE)?

How does the current ROE for Formycon AG (FYB.DE) compare to its historical average?